Budesonide, known as budesonide powder inhaler, is an inhaled epothilone, 200-800 mcg once, twice a day for adults, and 200-400 mcg once, twice a day for children, and terbutaline, known as terbutaline sulfate nebulized solution, is a long-acting beta agonist, 5 mg once, three times a day for adults and children over 20 kg, and 2.5 mg once for children under 20 kg , up to four times a day, both require nebulizer administration.
Both can be administered through a nebulizer by holding the vial in one hand, twisting the cap, opening the cap, squeezing the medication into the nebulizer reservoir, nebulizing and inhaling, and rinsing the mouth after the medication has been inhaled.
Budesonide powder inhaler is an inhaled glucocorticoid drug, indications include the treatment of bronchial asthma, chronic obstructive pulmonary disease, adverse reactions include mild throat irritation, cough, hoarseness, oropharyngeal Candida infections, skin rashes, urticaria and so on. Contraindications are prohibited for those who are allergic to budesonide.
Terbutaline Sulfate Nebulized Solution is mainly used to relieve bronchospasm caused by bronchial asthma, emphysema, and chronic bronchitis. Adverse reactions include headache, tremor, hypokalemia, tachycardia, palpitations, and muscle cramps. Contraindications include hypersensitivity to the components of terbutaline sulfate.
The above drugs need to be used in regular hospitals to determine the diagnosis, under the guidance of the doctor’s standardized use, do not self-medication, so as not to lead to adverse consequences.